Distributed Ventures Research
Investment Thesis
Distributed Ventures is a specialized venture capital fund focused on precision capital deployment in the risk ecosystem across health, insurance, and wealth. The fund's core conviction is that "risk becomes opportunity when paired with the right capital." Founded in 2024 as a spin-out from NFP Ventures (backed by Aon, a major insurance broker), Distributed Ventures brings deep operational and commercial expertise to early-stage founders building technologies that help risk-bearing entities and individuals better manage risk and improve their lives.
The firm believes that founders innovating at the intersection of health, insurance, and wealth—verticals where regulatory complexity, customer concentration, and capital intensity create natural barriers to entry—need more than just capital. They need strategic guidance, commercial distribution channels, and access to a network of large incumbents and strategic LPs.
Investment Thesis Deep Dive
Core Philosophy: Risk management and mitigation is undergoing digital transformation. Legacy systems in health, insurance, and wealth are ripe for disruption by technically sophisticated founders who understand the unique operational challenges of these verticals.
Competitive Advantage: The firm's LPs include major insurance brokers, insurance carriers, and wealth management platforms (Aon, Fiducient Advisors, Teladoc, and others). This creates direct buyer access, commercial pilot opportunities, and validation channels that most founders cannot replicate.
Value Add: Distributed Ventures doesn't position itself as a traditional venture capital firm. Instead, they position themselves as "precision capital at the frontier of risk," emphasizing:
- Go-to-market strategy development
- Enterprise distribution channel access
- Risk management guidance
- Board-level operational support
- Access to 265K+ corporate clients through LP network
Sector Focus
Distributed Ventures concentrates exclusively on three sectors where risk is a material concern:
1. Health (Employer Solutions & Digital Health)
- Virtual care platforms and digital clinics
- Workplace health benefits optimization
- Healthcare delivery innovations
- Personalized care technologies
- Chronic disease management
- Male reproductive health
- Digestion and gastrointestinal care Example portfolio companies: Sage, Cylinder, Posterity Health, Tuned, Wellth, Pillar HR
2. Insurance (InsurTech)
- Digital insurance distribution and underwriting
- Claims automation and optimization
- Risk assessment and pricing technologies
- Compliance and verification automation
- Real estate insurance innovation
- Specialty insurance platforms Example portfolio companies: Honeycomb Insurance, CoverTree, Indio, TrustLayer, Marble
3. Wealth (FinTech & Wealth Management)
- Financial advisory automation and compliance tools
- Retirement planning solutions
- Payroll and contractor benefits platforms
- Lending and credit solutions
- Fee benchmarking and analysis tools Example portfolio companies: Focal, Wingspan, PlanFees, Presta, 401kplans, Armadillo
Stage Focus
Distributed Ventures focuses on Seed and Series A investments:
- Seed: Primary focus, $1M-$3M typical checks
- Series A: Secondary focus, $3M-$5M typical checks
- Follow-on reserves: Company practices reserve-heavy investing, allocating ~50% of fund for follow-on investments
The firm explicitly states a target of "15-20% ownership" at both stages, indicating willingness to lead or co-lead rounds.
Check Size
- Typical range: $1M-$5M
- Seed stage: $1M-$3M
- Series A: $3M-$5M
- Target ownership: 15-20%
From the API data and website, we know the firm already has checkSizeMin: 1000000 and checkSizeMax: 5000000 configured.
Lead Tendency
Leads: The firm actively leads seed and series A rounds. Recent investments show Distributed Ventures as lead or co-lead investor in most announcements (e.g., Focal $5M seed co-lead, Posterity Health Series A with participation).
Recent Activity
Fund Status: Fund I ($155M raised from 2024) is in actively deploying phase. The firm has been investing steadily through 2024-2025.
Recent Notable Investments (Last 12+ months):
- Posterity Health: Series A follow-on (2025)
- Focal: $5M seed co-lead (2025)
- Wingspan: Portfolio follow-on for Series B (2024-2025)
- Sage: Portfolio follow-on for Series B $35M (2024)
- TrustLayer, Honeycomb, Marble, CoverTree: Seed/Series A participants
Exit Activity:
- 8+ portfolio companies have achieved acquisitions (Ascend, CoverTree, Focal, Honeycomb, Indio, Posterity Health, RxSaveCard, Sage)
- Multiple portfolio companies in growth mode: Wingspan $54M raised total, Sage $35M Series B, Honeycomb $36M Series B
Last Known Activity: February 2025 (Posterity Health Series A)
Portfolio Overview
The portfolio spans 20+ companies across health, insurance, and wealth verticals:
Health/Employer Solutions (9 companies):
- Sage: Senior living operations platform ($35M Series B)
- Cylinder: Virtual digestive health platform
- Posterity Health: Male reproductive health
- Tuned: Hearing benefits platform
- Wellth: Chronic disease adherence
- Pillar: Interview intelligence for HR
- RxSaveCard: Pharmacy benefits discount
- CVRD: Federal contractor benefits
Insurance (8 companies):
- Honeycomb Insurance: Real estate insurance, $36M Series B
- CoverTree: Specialty personal lines insurance (acquired)
- Ascend: Insurance billing automation (acquired)
- Indio: Insurance application platform
- Marble: Insurance aggregation platform
- TrustLayer: Risk management verification
Wealth/FinTech (8 companies):
- Focal: AI for financial advisors, $5M seed
- Wingspan: Payroll for contractors, $24M Series B
- 401kplans: 401(k) marketplace (acquired)
- PlanFees: Fee benchmarking
- Presta: Digital lending
- Armadillo: Home warranty subscription
Team
Investment Team:
- Shawn Ellis (Managing Partner): Leads the firm
- Janet Xu (Senior Principal): Portfolio management and due diligence
- Hylton Irons (Senior Associate): Deal sourcing and evaluation
- Antonio Calderon (Senior Associate): Technical due diligence
- Joseph Flanagan (Growth Partner): Go-to-market and commercial strategy for portfolio companies
Advisory Board (Deep Domain Expertise):
- Patrick Croke (Advisor): Former Sidley Austin partner, expert in M&A and fund formation
- Matt Levin (Advisor): CEO of Modern Health, healthcare and HR tech expertise
- Lon Chow (Advisor): Seasoned venture investor with 20+ years experience
- Doug Hammond (Advisor): Former CEO of NFP (insurance broker)
- Bob DiMeo (Advisor): Chairman of Fiducient Advisors (wealth management)
- Lisa Garvy (Advisor): SVP Strategic Partnerships at Teladoc Health
- Sander Duncan (Advisor): Healthcare investor and operator, founder of Sespe Health Holdings
The advisory board is particularly notable—it reflects the firm's strategic LP base and domain expertise in insurance, healthcare, and wealth management.
Geographic Focus
Primary: United States (headquarters in New York, NY)
The firm emphasizes US-based investments with portfolio spread across major markets (CA, NY, IL, and other tech hubs).
Decision Process
Structure: Partnership-based decision making. The core team (Ellis, Xu, Irons, Calderon) appears to make investment decisions with advisory board input.
Timeline: No specific public guidance, but given the $1-5M check sizes and deep diligence in specialized verticals, likely 4-8 weeks from introduction to commitment.
Governance
Board Participation: Distributed Ventures typically takes board seats or board observer rights in portfolio companies, as stated on their website ("Board seat or board observer rights").
Founder Preferences
Based on portfolio analysis:
- Domain Expert Founders: Founders with 10+ years in their vertical (healthcare operators, insurance professionals, fintech veterans)
- Technical Depth: Companies need defensible technology moats in regulated verticals
- Customer Traction: Preference for founders with early customer validation and willingness to work with LP network for pilots
- Vertical Focus: Founders must be deeply focused on health, insurance, or wealth—no generalist plays
- Go-to-Market Sophistication: B2B commercial savvy matters; founders should be prepared to work with enterprise customers
Anti-Thesis
Based on portfolio absence and public positioning:
- No consumer apps: The firm avoids consumer-focused businesses without B2B/B2C2B elements
- No pure infrastructure plays: Not interested in developer tools or infrastructure unrelated to health/insurance/wealth
- No international focus: All portfolio companies appear US-based
- No pre-seed stage: Firm explicitly focuses on Seed and Series A
Key Competitive Positioning
Differentiation from other VCs:
- Strategic LP base (not just capital providers, but customers)
- Deep domain expertise via advisory board
- Go-to-market support via Growth Partner
- Operating experience in insurance/healthcare/wealth
- Board governance with experienced operators
Co-Investors: Distributed Ventures works with complementary investors including Georgetown Equity Partners, First Round Capital, and industry-focused funds.
Fund Information
Fund I: $155M (closed 2024, spun from NFP Ventures)
LP Base:
- Aon (insurance broker, strategic anchor LP)
- Insurance carriers (direct customer access)
- Wealth management firms (Fiducient, others)
- Family offices and institutional investors
LP Statistics (from website):
- 20+ years combined operating experience
- $15B LP insurance GWP (Gross Written Premiums)
- $50B LP AUM (Assets Under Management)
- $400B+ LP AUI (Assets Under Administration)
- 265K+ LP corporate clients
These numbers highlight the firm's unique LP base—they're not traditional VCs but operating companies and wealth managers.
Investment Process Insights
Inbound: Contact through [email protected] or via their website form.
Due Diligence Focus:
- Customer traction and pilots within LP network
- Regulatory and compliance pathway clarity
- Unit economics and path to profitability
- Technology defensibility in specialized domain
- Founder-LP relationships and co-investment potential
Notable Insights
- Network Effect: The firm leverages a unique LP base of insurance companies, wealth managers, and brokers as both capital and customer sources
- Operational Value: Heavy emphasis on go-to-market support via dedicated Growth Partner
- Portfolio Concentration: Strongly concentrated in health/insurance/wealth—not a diversified fund
- Exit Strategy: Mix of acquisitions (corporate buyers from LP base) and growth to Series B/C for select companies
- Market Timing: Fund created in 2024, capturing digital transformation wave in traditional industries